Journal
KIDNEY RESEARCH AND CLINICAL PRACTICE
Volume 41, Issue 4, Pages 473-481Publisher
KOREAN SOC NEPHROLOGY
DOI: 10.23876/j.krcp.21.210
Keywords
Cinacalcet; Hyperparathyroidism; Kidney transplantation; Parathyroidectomy
Categories
Ask authors/readers for more resources
In patients with tertiary hyperparathyroidism after kidney transplantation, both parathyroidectomy and cinacalcet treatment effectively improve serum calcium and PTH levels, with parathyroidectomy group showing better long-term outcomes.
Background: Hyperparathyroidism is common in patients with chronic kidney disease with reduced renal function and has been ob-served after kidney transplantation. The optimal treatment for cases in which hyperparathyroidism persists after kidney transplanta-tion has not been determined. Methods: This retrospective study included 83 patients with tertiary hyperparathyroidism who underwent kidney transplantation be-tween 2000 and 2018 at a single tertiary center in Korea. Sixty-four patients underwent parathyroidectomy and 19 patients were treated with cinacalcet following renal transplantation. Biochemical parameters and clinical outcomes were compared between the two groups. Results: Serum calcium and parathyroid hormone (PTH) levels improved in both the parathyroidectomy and cinacalcet groups. One year after treatment, parathyroidectomy resulted in a lower mean serum calcium level than cinacalcet (9.7 ?? 0.7 mg/dL vs. 10.5 ?? 0.7 mg/dL, p = 0.001). Regarding serum PTH, the parathyroidectomy group showed a significantly lower PTH level than the cinacalcet group at 6 months (129.1 ?? 80.3 pg/mL vs. 219.2 ?? 92.5 pg/mL, p = 0.002) and 1 year (118.8 ?? 75.5 pg/mL vs. 250.6 ?? 94.5 pg/ mL, p < 0.001). There was no statistically significant difference in the incidence of kidney transplant rejection, graft failure, cardiovas-cular events, fracture risk, or bone mineral density changes between the two groups. Conclusion: Parathyroidectomy appears to reduce PTH and calcium levels effectively in tertiary hyperparathyroidism. However, creati-nine level and allograft rejection should be monitored closely.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available